Medically supervised Semaglutide injections and IV Vitamin Therapy for sustainable weight loss, appetite control, and metabolic balancecompounded by licensed pharmacies, tailored to your bodys needs, and administered by healthcare professionals at Atlantic Endocrinology
Evidence supports even simple activities like: Higher daily step counts Resistance training to preserve lean mass Maintaining muscle to support metabolic health (muscle burns more resting calories) Optimize Medication Dose Maximum average weight loss in GLP-1/GIP clinical trials occurred at higher doses
However, percentage weight loss tends to be relatively similar across starting weights, meaning someone starting at 200 pounds and someone starting at 300 pounds may both lose roughly 15% by 68 weeks, even though the absolute numbers differ dramatically
in patients at increased risk of hypoglycemia consider reducing the dose of insulin at initiation of semaglutide, followed by careful titration
Individual patient factors, including hydration status, dietary habits, and concurrent medications may influence headache occurrence
